90Y Radioembolization for Hepatic Malignancy in Patients with Previous Biliary Intervention: Multicenter Analysis of Hepatobiliary Infections.
Sign Up to like & getrecommendations! Published in 2018 at "Radiology"
DOI: 10.1148/radiol.2018170962
Abstract: Purpose To determine the frequency of hepatobiliary infections after transarterial radioembolization (TARE) with yttrium 90 (90Y) in patients with liver malignancy and a history of biliary intervention. Materials and Methods For this retrospective study, records… read more here.
Keywords: hepatobiliary infections; biliary intervention; malignancy; radioembolization ... See more keywords
Abstract 2583: AKT2 as the determining factor for PTEN loss-induced liver malignancy
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-2583
Abstract: Liver malignancies consist of hepatocellular carcinoma (HCC) with the highest occurrence, intrahepatic cholangiocarcinoma (iCCA), and serval rare subtypes, which is the third lethal cause among all cancer types worldwide. PTEN is a well-known tumor suppressor… read more here.
Keywords: pten loss; determining factor; liver malignancy; loss ... See more keywords
Ablative Therapy in Non-HCC Liver Malignancy
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15041200
Abstract: Simple Summary Liver malignancy affects thousands of people, and its treatment is constantly evolving. Ablative therapies are a series of minimally invasive modalities that treat these tumors in combination with other established forms of treatment… read more here.
Keywords: non; liver; liver malignancy; ablative therapy ... See more keywords